{
    "medicine_id": "10debad059c7388116ee4172edef9ae2e6e0c1ba",
    "platform_id": "DB01263",
    "metadata": {
        "name": "Noxafil 40 mg ml Suspension",
        "composition": "40 mg ml Posaconazole",
        "clinical_particulars": {
            "therapeutic_indications": "For prophylaxis of invasive em Aspergillus em and em Candida em infections in patients 13 years of age and older who are at high risk of developing these infections due to being severely immunocompromised as a result of procedures such as hematopoietic stem cell transplant HSCT recipients with graft versus host disease GVHD or due to hematologic malignancies with prolonged neutropenia from chemotherapy Also for the treatment of oropharyngeal candidiasis including oropharyngeal candidiasis refractory to itraconazole and or fluconazole Posaconazole is used as an alternative treatment for invasive aspergillosis em Fusarium em infections and zygomycosis in patients who are intolerant of or whose disease is refractory to other antifungals",
            "contraindications": {
                "disease": "During the clinical trials some patients received posaconazole up to 1600 mg day with no adverse events noted that were different from the lower doses In addition accidental overdose was noted in one patient who took 1200 mg BID for 3 days No related adverse events were noted by the investigator",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Posaconazole is an antifungal agent structurally related to itraconazole It is a drug derived from itraconzaole through the replacement of the chlorine substituents with flourine in the phenyl ring as well as hydroxylation of the triazolone side chain These modifications enhance the potency and spectrum of activity of the drug Posaconazole can be either fungicial or fungistatic in action",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00681",
                        "description": "The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Sildenafil can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "Omeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "Lansoprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00736",
                        "description": "Esomeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05351",
                        "description": "Dexlansoprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13762",
                        "description": "Dexrabeprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11964",
                        "description": "Ilaprazole can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Trastuzumab emtansine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Almotriptan can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The metabolism of Bedaquiline can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The metabolism of Brexpiprazole can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08875",
                        "description": "The metabolism of Cabozantinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ceritinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The metabolism of Daclatasvir can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The metabolism of Fesoterodine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The metabolism of Flibanserin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The metabolism of Guanfacine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The serum concentration of SN 38 an active metabolite of Irinotecan can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The metabolism of Milnacipran can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04835",
                        "description": "The metabolism of Maraviroc can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The metabolism of Mifepristone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Palbociclib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The serum concentration of Quetiapine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The metabolism of Saxagliptin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vilazodone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Vindesine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vinorelbine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Vincristine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Vinblastine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05168",
                        "description": "The metabolism of Vintafolide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The metabolism of Vincamine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "The serum concentration of Tadalafil can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The serum concentration of Tolterodine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The serum concentration of Posaconazole can be decreased when it is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The serum concentration of Warfarin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The serum concentration of Acenocoumarol can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The serum concentration of R warfarin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The serum concentration of S Warfarin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The metabolism of Eplerenone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The metabolism of Salmeterol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The serum concentration of Riociguat can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The serum concentration of Methysergide can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Cabergoline can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The serum concentration of Dihydroergotamine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The serum concentration of Methylergometrine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The serum concentration of Lisuride can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The serum concentration of Ergotamine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The serum concentration of Pergolide can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The serum concentration of Bromocriptine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The serum concentration of Ergometrine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The serum concentration of Dihydroergocornine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The serum concentration of Dihydroergocryptine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "The serum concentration of Terguride can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The serum concentration of Atorvastatin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The serum concentration of Posaconazole can be decreased when it is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The serum concentration of Astemizole can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The serum concentration of Boceprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The serum concentration of Fluticasone propionate can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The metabolism of Barnidipine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Droperidol"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Flecainide"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Promazine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dolasetron"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ondansetron"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Zuclopenthixol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Lorazepam can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Phentermine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The metabolism of Azithromycin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Famciclovir can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Cephalexin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Norethisterone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Fenofibrate can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Rosuvastatin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Drospirenone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "The metabolism of Roflumilast can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Rufinamide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The metabolism of Linagliptin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The metabolism of Vorapaxar can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The metabolism of Suvorexant can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Nintedanib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The metabolism of Gilteritinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Tenofovir can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of St John s Wort can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Tazemetostat can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Ebastine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Cisapride can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The metabolism of Osimertinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Ribociclib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Fasudil"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Tranilast"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Agmatine"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Darodipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Niludipine"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Caroverine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Fish oil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The therapeutic efficacy of Posaconazole can be increased when used in combination with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Posaconazole can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Posaconazole may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Posaconazole can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The metabolism of Ivacaftor can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The metabolism of Tezacaftor can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Carfilzomib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Valspodar can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Pibrentasvir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Glecaprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Telaprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Simeprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Mirabegron can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Asunaprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Velpatasvir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Rifamycin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Voxilaprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Rucaparib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Fedratinib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The metabolism of Hydrocodone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cariporide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Solifenacin"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxepin is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of QTc prolongation can be increased when Desipramine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of QTc prolongation can be increased when Epinastine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Posaconazole can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Vandetanib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Romidepsin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Cobimetinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dacomitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Crizotinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Regorafenib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Venetoclax can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Ivosidenib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The metabolism of Digitoxin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Dabrafenib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Lomitapide"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The metabolism of Tolvaptan can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Doxorubicin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Acalabrutinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Teniposide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Ixabepilone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Midostaurin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Bosutinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Cyclophosphamide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Bicalutamide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Duvelisib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01390",
                        "description": "Sodium bicarbonate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "Calcium carbonate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "Magaldrate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Magnesium trisilicate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "Aluminium acetoacetate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "Hydrotalcite can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "Magnesium peroxide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Almasilate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "Aluminium glycinate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "Aloglutamol can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "Calcium silicate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "Aluminium phosphate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "Famotidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Methantheline can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08805",
                        "description": "Metiamide can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08806",
                        "description": "Roxatidine acetate can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12770",
                        "description": "Lafutidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12884",
                        "description": "Lavoltidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13760",
                        "description": "Niperotidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "Nizatidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine can cause a decrease in the absorption of Posaconazole resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The metabolism of Flunisolide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Triamcinolone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The metabolism of Fludrocortisone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The metabolism of Trilostane can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The metabolism of Corticotropin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Cortisone acetate can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Paramethasone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The metabolism of Fluprednisolone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Meprednisone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The metabolism of Melengestrol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Cortivazol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Prednylidene can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Cloprednol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Cortisone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Betamethasone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The metabolism of Prednisone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Hydrocortisone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The metabolism of Prednisolone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The metabolism of Methylprednisolone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Budesonide can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Dexamethasone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The metabolism of Aldosterone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Prucalopride can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Silodosin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Apixaban can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Odanacatib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The serum concentration of Lenvatinib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Dasabuvir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Ombitasvir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Talinolol can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Ertugliflozin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Revefenacin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Tenofovir disoproxil"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Paritaprevir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Rivaroxaban can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Belinostat can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Prednisolone phosphate can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The metabolism of Amlodipine can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Zolpidem can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Posaconazole is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The therapeutic efficacy of Dicoumarol can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The therapeutic efficacy of Phenindione can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The therapeutic efficacy of 4 hydroxycoumarin can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The therapeutic efficacy of Coumarin can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The therapeutic efficacy of Fluindione can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The therapeutic efficacy of Clorindione can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The therapeutic efficacy of Diphenadione can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The therapeutic efficacy of Tioclomarol can be increased when used in combination with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12240",
                        "description": "The risk or severity of adverse effects can be increased when Posaconazole is combined with Polatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The serum concentration of Deflazacort can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The serum concentration of Eszopiclone can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Pexidartinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB05154",
                        "description": "The serum concentration of Pretomanid can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The metabolism of Entrectinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Posaconazole may increase the QTc prolonging activities of Lefamulin"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The serum concentration of Elexacaftor can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Posaconazole can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB15091",
                        "description": "The metabolism of Upadacitinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The serum concentration of Lumateperone can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Fosphenytoin can be decreased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Phenytoin can be decreased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The metabolism of Rimegepant can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The serum concentration of Osilodrostat can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The serum concentration of Lovastatin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Posaconazole may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15102",
                        "description": "The metabolism of Pemigatinib can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Ripretinib"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Posaconazole can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB12674",
                        "description": "The serum concentration of Lurbinectedin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The serum concentration of Oliceridine can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Posaconazole can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Posaconazole can be increased when it is combined with Pralsetinib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}